Device Trial Radar · NCT04529616
Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes
Last checked: Nov 19, 2026Latest source record: Feb 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
79
Actual
Start
May 22, 2020
Primary completion
Oct 1, 2022
Study completion Oct 1, 2022
Sponsor
- Lead sponsor
- RxSight, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 27, 2020
Design
- Study type
- Interventional
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to evaluate, for the visual correction of aphakia, whether the RxSight Light Adjustable Lens (LAL) and Light Delivery Device (LDD) can be used to improve visual outcomes after performing adjustments of the LAL with the LDD. This is an exploratory study. No primary effectiveness endpoints will be identified.
Conditions
- Aphakia
- Cataract
Interventions
Light Adjustable lens (LAL) and Light Delivery Device (LDD)Device
Eligible eyes will receive Light adjustable lens with Light delivery Device treatments
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent of Eyes With Uncorrected Distance Visual Acuity (UCDVA) of 20/20 or BetterTime frame: 3 months post op
- Proportion of Eyes Simultaneously With (1) Monocular UCDVA of 20/25 or Better and (2) Monocular Uncorrected Intermediate Visual Acuity (UCIVA) of 20/32 or Better and (3) Monocular Uncorrected Near Visual Acuity (UCNVA) of 20/40 or BetterTime frame: 12 months post op
Locations
1 site in 1 country. Site status is shown where the registry gives one.
CODET Vision Institute
Tijuana, Mexico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.